Market Open

ABBV
Abbvie
$ 255.46
0.76%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a few seconds ago

Abbvie News

Latest Abbvie Stock News & ABBV Headlines

How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend?
2 days ago | fool.com
AbbVie Is Already a Dividend King. Here's Why the $10.9 Billion Apogee Deal Could Make It a Dynasty
10 days ago | fool.com
AbbVie Inc (ABBV) Stock Down 0.7% but Still Overvalued -- GF Score: 76/100
11 days ago | gurufocus.com
AbbVie Inc (ABBV) Stock Down 0.7% but Still Overvalued -- GF Score: 76/100
11 days ago | gurufocus.com
Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner
11 days ago | 247wallst.com
AbbVie (ABBV) Moves 4.2% Higher: Will This Strength Last?
22 days ago | zacks.com
AbbVie to Buy Apogee Therapeutics for $10.9 Billion
a month ago | youtube.com
AbbVie to acquire Apogee Therapeutics in $10.9B deal
a month ago | proactiveinvestors.com
AbbVie Expands Immunology Footprint With Apogee $11 Billion Acquisition
a month ago | benzinga.com
AbbVie: Immunology Cash Flow Funds Oncology Expansion
a month ago | seekingalpha.com
Load More

Download App

Keep track of your holdings and explore over 48,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Open

ABBV
Abbvie
$ 255.46
0.76%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a few seconds ago